ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Bayer
AstraZeneca
Myeloid Therapeutics
Boehringer Ingelheim
Tanabe Pharma America, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
National Institutes of Health Clinical Center (CC)
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
Instituto do Cancer do Estado de São Paulo
Royal Marsden NHS Foundation Trust
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Zumutor Biologics Inc.
Eli Lilly and Company
Genentech, Inc.
Universitair Ziekenhuis Brussel
Institut Bergonié
CureOne